Skip to main content
. Author manuscript; available in PMC: 2025 Jan 13.
Published in final edited form as: Am J Hematol. 2012 Mar 31;87(7):687–691. doi: 10.1002/ajh.23180

Figure 1.

Figure 1

Association between adherence and costs (2005 US dollars) [16]. MPR, medication possession ratio. Note: Costs are over the first year after initiation of imatinib. Low MPR: <85%; high MPR: ≥85%. *P < 0.001. †P = 0.001. ‡P = 0.021.